This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_URINARY_TRACT_NAS_EXALLC for full statistics.
Malignant neoplasm of other and unspecified urinary organs
C3_URINARY_TRACT_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
94 |
4. Check minimum number of eventsNone |
94 |
5. Include endpointsNone |
94 |
6. Filter based on genotype QC (FinnGen only) |
94 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified urinary organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 94 | 27 | 67 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 73.66 | 70.71 | 74.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 93
- Matched controls
- 928
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UKC02
NOMESCO Finland
Cystoscopy
26.0
39.0
79
165
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
47.7
36.4
44
17
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
33.3
30
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
31.1
28.3
38
20
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
159.5
23.8
24
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
75.2
21.0
23
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
20.6
19
*
KAC20
NOMESCO Finland
Nephroureterectomy
125.8
19.4
20
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
56.6
19.2
22
5
UKB02
NOMESCO Finland
Retrograde ureteroscopy
42.9
19.0
23
7
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
30.4
19.0
25
11
R31
ICD-10 Finland
Unspecified haematuria
8.2
18.0
49
111
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
62.8
17.8
20
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
205.3
17.1
17
*
8120/3-C68.0
ICD-O-3
Transitional cell carcinoma, NOS, of urethra
+∞
16.1
15
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
15.0
14
*
ZX136
NOMESCO Finland
Intravesicalis
54.3
12.3
14
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
6.1
12.0
37
90
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
49.8
11.2
13
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
25.1
11.1
15
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.8
10.9
20
21
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
14.6
10.9
18
15
8000/3-C68.9
ICD-O-3
Neoplasm, malignant of urinary system, NOS
+∞
10.6
10
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
19.5
10.3
15
9
KCC10
NOMESCO Finland
Cystoprostatectomy
45.3
10.2
12
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
61.6
9.9
11
*
130
Kela drug reimbursment
Malignant tumour
6.2
9.8
28
60
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.5
9.8
20
26
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
20.3
9.7
14
8
D41.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urethra
+∞
9.5
9
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
13.5
9.5
16
14
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
9.3
43
156
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
55.4
8.9
10
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
30.8
8.7
11
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
98.6
8.6
9
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
8.5
8
*
J01MA02
ATC
ciprofloxacin; systemic
3.6
7.9
57
285
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
13.5
7.9
13
11
J01EA01
ATC
trimethoprim; systemic
3.7
7.7
40
156
8070/3-C68.0
ICD-O-3
Squamous cell carcinoma, NOS, of urethra
+∞
7.4
7
*
J01MA12
ATC
levofloxacin; systemic
3.6
7.0
36
137
TJF80
NOMESCO Finland
Ostomy education
24.6
6.8
9
*
H02AB02
ATC
dexamethasone; systemic
5.0
6.8
22
54
B01AB10
ATC
tinzaparin; parenteral
5.7
6.7
19
40
R33
ICD-10 Finland
Retention of urine
4.5
6.6
24
67
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
74.8
6.5
7
*
J01CA08
ATC
pivmecillinam; oral
3.4
6.5
37
151
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
19.7
6.4
9
5
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
6.3
6
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
6.3
6
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
6.3
30
107
JN4CD
NOMESCO Finland
Very extensive body CT
6.2
6.2
16
30
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
49
39
25.16
54.83
5.6
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
58
226
5.09
13.79
7.1
3.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
294
3.38
7.71
7.4
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
59
311
3.41
7.70
5.9
4.3
—
—
—
0
0
(4035726)
19
61
3.65
5.26
1.5
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
158
2.80
5.09
2.8
2.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
20
72
3.26
4.63
9.4
4.1
kpa
6.0
5.5
1.35
20
67
(3031040) Bacteria [#/volume] in Urine by Automated count
70
482
2.77
4.55
11.4
4.9
—
439.2
—
0
16
(3044640) Blood type and Crossmatch panel - Blood
42
229
2.51
4.47
3.1
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
22
87
3.00
4.35
1.5
1.4
—
—
—
0
0
(3012544) pH of Venous blood
20
75
3.12
4.32
9.5
4.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
32
4.15
4.23
4.2
2.0
u/ml
0.3
0.4
—
6
17
(40768804) Tissue Pathology biopsy report
46
270
2.38
4.09
3.5
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
67
467
2.51
3.99
7.8
4.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
43
258
2.23
3.50
6.7
4.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
25
119
2.50
3.44
2.2
1.7
s
30.0
29.8
0.08
25
114
(3000991) Gas panel - Venous blood
16
63
2.86
3.15
23.3
7.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
36
211
2.14
3.03
9.0
3.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
39
3.06
2.57
22.7
7.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
130
2.14
2.41
8.4
3.2
e6/l
2.5
2.1
0.09
16
83
(3035350) Ketones [Presence] in Urine by Test strip
48
334
1.89
2.38
6.5
4.0
estimate
0.0
0.0
0.00
16
74
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
51
364
1.88
2.32
15.5
5.7
mmol/l
1.2
1.2
0.44
41
300
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
24
3.54
2.23
2.4
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
127
2.07
2.19
8.2
2.9
e6/l
4.3
1.2
0.37
15
79
(3018418) pH of Serum or Plasma
33
212
1.86
2.03
8.6
3.9
ph
7.4
7.4
—
9
45
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
45
2.64
2.01
1.5
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
147
1.95
2.00
5.4
3.6
—
—
—
0
0
(3015736) pH of Urine
37
248
1.81
1.99
6.4
3.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
47
339
1.77
1.97
8.7
5.5
estimate
0.0
0.0
0.00
15
68
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
11
4.73
1.96
1.2
1.7
%
59.8
61.5
—
5
11
(40761535) Cells panel - Urine sediment
13
59
2.40
1.94
5.5
3.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
50
369
1.76
1.92
14.8
8.1
e9/l
4.6
4.5
0.12
45
318
(3024561) Albumin [Mass/volume] in Serum or Plasma
46
333
1.75
1.88
7.7
3.9
g/l
31.7
34.4
2.71
41
309
(3009261) Glucose [Presence] in Urine by Test strip
47
343
1.74
1.86
6.5
4.1
estimate
0.0
0.0
0.00
16
66
(42870588) Differential panel, method unspecified - Blood
34
226
1.79
1.86
6.6
4.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
12
4.33
1.84
1.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
42
299
1.73
1.80
6.7
5.2
%
3.1
2.5
0.62
36
273
(3019069) Monocytes/100 leukocytes in Blood
42
300
1.72
1.78
6.9
5.5
%
9.5
9.0
0.39
36
273
(3022096) Basophils/100 leukocytes in Blood
41
294
1.70
1.69
6.9
5.2
%
0.7
0.5
0.53
35
268
(3002030) Lymphocytes/100 leukocytes in Blood
42
306
1.67
1.62
7.1
5.6
%
19.7
24.2
1.82
35
276
(3018010) Neutrophils/100 leukocytes in Blood
41
298
1.67
1.59
6.6
5.3
%
64.1
60.4
0.95
34
272
(3003396) Base excess in Arterial blood by calculation
18
103
1.92
1.54
16.3
5.4
mmol/l
-1.5
1.3
1.33
12
85
(40761536) Microorganisms panel - Urine sediment
12
60
2.15
1.45
7.7
4.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
44
335
1.59
1.37
7.2
5.1
e9/l
0.2
0.2
0.26
38
287
(3022313) Gas panel - Capillary blood
8
37
2.27
1.25
5.6
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
28
196
1.61
1.22
7.0
4.1
estimate
0.0
0.0
0.00
11
66
(3032080) INR in Blood by Coagulation assay
44
343
1.53
1.20
13.8
8.9
inr
1.5
1.4
0.18
13
101
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
0
33
0.00
1.19
0.0
1.6
—
1.9
—
0
23
(3030981) Hyaline casts [#/volume] in Urine by Automated count
10
52
2.03
1.11
3.1
3.8
e6/l
0.3
0.2
—
10
52
(3047181) Lactate [Moles/volume] in Blood
5
21
2.46
1.10
11.4
7.2
mmol/l
1.3
1.2
—
5
21
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
46
2.06
1.07
1.8
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
10
53
1.99
1.06
1.9
3.0
ml/min/173m2
32.4
55.5
—
5
20
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
53
1.99
1.06
6.8
1.8
nmol/l
556.8
371.8
—
10
48
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
34
2.14
1.05
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
41
324
1.47
1.01
7.4
4.8
e9/l
0.7
0.6
1.00
33
273
(3006315) Basophils [#/volume] in Blood
41
324
1.47
1.01
7.3
4.9
e9/l
0.0
0.0
0.14
33
276
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
62
1.88
0.99
2.4
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
34
262
1.47
0.94
7.9
4.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
41
329
1.44
0.92
7.4
5.0
e9/l
1.5
1.7
0.68
34
288
(3042936) Bacteria identified in Isolate by Culture
17
113
1.62
0.90
3.1
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
11
173
0.59
0.86
1.8
1.7
mmol/l
1.2
1.2
0.01
11
141
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
22
158
1.51
0.85
2.7
2.7
mmol/l
2.5
2.5
0.25
17
138
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
24
0.00
0.80
0.0
4.7
—
35.2
—
0
13
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
84
1.64
0.76
7.3
4.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
10
60
1.75
0.75
7.5
3.0
kpa
4.5
4.3
—
10
55
(40758558) Short blood count panel - Blood
22
163
1.46
0.73
9.1
6.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
27
1.90
0.69
2.4
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
55
480
1.35
0.69
4.6
4.6
—
—
—
0
0
(3019225) pH of Specimen
11
71
1.62
0.65
3.8
3.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
21
0.00
0.61
0.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
19
142
1.42
0.60
1.2
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
71
652
1.36
0.58
30.5
17.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
26
207
1.35
0.58
2.7
2.0
mg/l
3.3
3.0
0.40
20
181
(3013512) EKG study
28
230
1.31
0.51
4.1
4.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
24
193
1.33
0.50
6.7
4.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
33
278
1.29
0.50
2.1
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
46
1.56
0.49
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
68
1.53
0.49
6.0
3.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
17
130
1.38
0.48
5.4
4.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
72
671
1.31
0.47
40.1
21.0
umol/l
127.9
87.3
3.22
72
671
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
31
1.65
0.44
1.4
1.9
—
—
—
0
0
(3020891) Body temperature
5
33
1.54
0.42
5.2
3.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
89
1.40
0.40
2.0
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
35
1.45
0.40
1.0
1.3
g/l
2.6
3.2
—
5
28
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
92
1.35
0.34
1.7
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
33
290
1.21
0.33
16.4
10.9
e9/l
0.0
0.0
0.50
27
237
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
53
1.35
0.31
2.0
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
321
1.20
0.31
2.0
2.1
pmol/l
95.1
89.8
0.30
23
168
(3022145) Colonoscopy Study observation
8
64
1.27
0.28
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
16
132
1.26
0.28
1.9
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
14
170
0.79
0.28
2.6
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
10
77
1.33
0.27
2.7
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
41
446
0.86
0.26
4.4
3.6
pmol/l
15.0
14.9
0.03
35
384
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
38
1.33
0.23
1.0
1.3
g/l
11.8
10.4
—
5
33
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.23
1.0
1.3
g/l
4.4
4.0
—
5
27
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.23
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
40
1.26
0.23
1.6
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.23
1.0
1.3
g/l
6.8
8.0
—
5
29
(3039443) Prostate specific Ag panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.4
—
2.2
—
0
12
(3008898) HLA-B27 [Presence]
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
52
1.16
0.19
4.8
4.7
mmol/l
22.7
24.8
—
6
52
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
55
577
0.89
0.18
4.6
4.5
mu/l
2.0
2.2
0.48
45
493
(40768797) Stomach Pathology biopsy report
10
82
1.25
0.18
1.1
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
65
627
1.12
0.15
4.9
5.5
mmol/l
6.0
6.1
0.44
55
558
(3000330) Specific gravity of Urine by Test strip
5
45
1.12
0.10
8.6
4.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
48
1.04
0.09
1.4
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
59
606
0.93
0.08
6.8
7.1
mmol/mol
41.7
42.2
0.16
53
549
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
39
374
1.07
0.08
4.2
5.5
ug/l
7.6
2.3
0.53
30
325
(3000494) Fungus identified in Specimen by Culture
9
84
1.08
0.07
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
20
213
0.92
0.07
2.9
3.1
ug/l
0.8
0.8
0.02
14
155
(3020682) Albumin/Creatinine [Ratio] in Urine
23
239
0.95
0.03
3.9
4.1
mg/mmol
29.9
8.1
0.54
18
156
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
64
631
1.04
0.03
4.3
5.8
mmol/l
2.3
2.4
0.46
58
561
(3009542) Hematocrit [Volume Fraction] of Blood
53
521
1.04
0.02
40.3
19.7
%
32.6
37.6
1.49
30
301
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
58
588
0.96
0.02
4.1
4.5
mmol/l
1.2
1.2
0.02
53
516
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
61
612
0.99
0.00
4.2
5.1
mmol/l
4.1
4.3
0.35
56
546
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
61
608
1.01
0.00
4.0
5.0
mmol/l
1.4
1.4
0.14
56
534
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
299
1.00
0.00
3.4
4.6
%
20.8
21.7
0.12
18
158
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
33
333
0.99
0.00
6.2
4.1
ng/l
56.4
59.5
0.05
28
267
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
61
0.98
0.00
1.5
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
69
0.86
0.00
2.7
2.3
u/l
23.7
33.6
—
6
56
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
89
1.01
0.00
18.0
8.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
11.3
—
0
5
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
13.3
—
0
9
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.0
—
200.0
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.1
—
0
5
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
59
1.02
0.00
1.5
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
13.9
—
0
5
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
9.0
—
0
5
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
6
0.00
0.00
0.0
1.0
—
1.5
—
0
6
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
23.6
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_URINARY_TRACT_NAS – Malignant neoplasm of other and unspecified urinary organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).